Wells Fargo’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.3M | Sell |
189,853
-90,192
| -32% | -$7.12M | ﹤0.01% | 1760 |
|
|
2025
Q4 | $22.2M | Sell |
280,045
-5,248
| -2% | -$395K | ﹤0.01% | 1433 |
|
|
2025
Q3 | $18.7M | Buy |
285,293
+75,436
| +36% | +$3.68M | ﹤0.01% | 1516 |
|
|
2025
Q2 | $8.29M | Sell |
209,857
-46,376
| -18% | -$1.52M | ﹤0.01% | 2064 |
|
|
2025
Q1 | $7.73M | Sell |
256,233
-74,776
| -23% | -$2.45M | ﹤0.01% | 2073 |
|
|
2024
Q4 | $11.6M | Sell |
331,009
-11,145
| -3% | -$417K | ﹤0.01% | 1748 |
|
|
2024
Q3 | $13.7M | Sell |
342,154
-24,407
| -7% | -$1.14M | ﹤0.01% | 1575 |
|
|
2024
Q2 | $17.5M | Sell |
366,561
-217,597
| -37% | -$8.92M | ﹤0.01% | 1333 |
|
|
2024
Q1 | $25.3M | Sell |
584,158
-10,092
| -2% | -$481K | 0.01% | 1090 |
|
|
2023
Q4 | $30.1M | Sell |
594,250
-23,680
| -4% | -$1.13M | 0.01% | 953 |
|
|
2023
Q3 | $28M | Buy |
617,930
+5,039
| +0.8% | +$208K | 0.01% | 923 |
|
|
2023
Q2 | $25.1M | Sell |
612,891
-13,259
| -2% | -$510K | 0.01% | 998 |
|
|
2023
Q1 | $22.4M | Buy |
626,150
+18,110
| +3% | +$680K | 0.01% | 1067 |
|
|
2022
Q4 | $23M | Sell |
608,040
-81,832
| -12% | -$3.44M | 0.01% | 1033 |
|
|
2022
Q3 | $30.5M | Sell |
689,872
-34,123
| -5% | -$1.44M | 0.01% | 856 |
|
|
2022
Q2 | $26.8M | Sell |
723,995
-118,289
| -14% | -$4.46M | 0.01% | 975 |
|
|
2022
Q1 | $31.2M | Buy |
842,284
+31,318
| +4% | +$1.03M | 0.01% | 1031 |
|
|
2021
Q4 | $24.7M | Sell |
810,966
-42,404
| -5% | -$1.33M | 0.01% | 1185 |
|
|
2021
Q3 | $28.6M | Buy |
853,370
+11,939
| +1% | +$450K | 0.01% | 1407 |
|
|
2021
Q2 | $33.6M | Sell |
841,431
-315,568
| -27% | -$12.4M | 0.01% | 1322 |
|
|
2021
Q1 | $52M | Buy |
1,156,999
+6,281
| +0.5% | +$350K | 0.01% | 1028 |
|
|
2020
Q4 | $65.1M | Buy |
1,150,718
+232,691
| +25% | +$11.6M | 0.02% | 840 |
|
|
2020
Q3 | $43.6M | Sell |
918,027
-49,422
| -5% | -$2.75M | 0.01% | 940 |
|
|
2020
Q2 | $57M | Buy |
967,449
+156
| +0% | +$8.68K | 0.02% | 796 |
|
|
2020
Q1 | $45.7M | Sell |
967,293
-60,411
| -6% | -$3.37M | 0.02% | 801 |
|
|
2019
Q4 | $62.1M | Sell |
1,027,704
-12,876
| -1% | -$767K | 0.02% | 819 |
|
|
2019
Q3 | $62.3M | Sell |
1,040,580
-35,724
| -3% | -$2.33M | 0.02% | 783 |
|
|
2019
Q2 | $69.2M | Buy |
1,076,304
+59,667
| +6% | +$4.22M | 0.02% | 759 |
|
|
2019
Q1 | $82.5M | Sell |
1,016,637
-121,671
| -11% | -$7.85M | 0.02% | 633 |
|
|
2018
Q4 | $61.5M | Sell |
1,138,308
-26,959
| -2% | -$1.37M | 0.02% | 717 |
|
|
2018
Q3 | $60.1M | Sell |
1,165,267
-43,436
| -4% | -$2.04M | 0.02% | 833 |
|
|
2018
Q2 | $50.4M | Buy |
1,208,703
+66,535
| +6% | +$2.95M | 0.01% | 908 |
|
|
2018
Q1 | $50.3M | Buy |
1,142,168
+38,839
| +4% | +$1.97M | 0.01% | 890 |
|
|
2017
Q4 | $55.5M | Sell |
1,103,329
-50,719
| -4% | -$2.78M | 0.02% | 833 |
|
|
2017
Q3 | $58.5M | Sell |
1,154,048
-14,967
| -1% | -$784K | 0.02% | 793 |
|
|
2017
Q2 | $59.5M | Sell |
1,169,015
-8,705
| -0.7% | -$405K | 0.02% | 780 |
|
|
2017
Q1 | $47.3M | Sell |
1,177,720
-20,643
| -2% | -$927K | 0.02% | 876 |
|
|
2016
Q4 | $57.3M | Buy |
1,198,363
+350,451
| +41% | +$13.9M | 0.02% | 761 |
|
|
2016
Q3 | $31.1M | Sell |
847,912
-22,875
| -3% | -$716K | 0.01% | 1014 |
|
|
2016
Q2 | $20.3M | Buy |
870,787
+23,619
| +3% | +$762K | 0.01% | 1298 |
|
|
2016
Q1 | $34.3M | Buy |
847,168
+261,241
| +45% | +$10.6M | 0.01% | 968 |
|
|
2015
Q4 | $36.3M | Buy |
585,927
+52,831
| +10% | +$2.85M | 0.01% | 932 |
|
|
2015
Q3 | $21.5M | Sell |
533,096
-20,232
| -4% | -$1.05M | 0.01% | 1256 |
|
|
2015
Q2 | $31.8M | Sell |
553,328
-25,377
| -4% | -$1.61M | 0.01% | 1049 |
|
|
2015
Q1 | $36.8M | Sell |
578,705
-18,025
| -3% | -$1.22M | 0.01% | 954 |
|
|
2014
Q4 | $36.8M | Buy |
596,730
+43,193
| +8% | +$2.13M | 0.01% | 927 |
|
|
2014
Q3 | $21.5M | Buy |
553,537
+8,986
| +2% | +$318K | 0.01% | 1210 |
|
|
2014
Q2 | $18.8M | Sell |
544,551
-93,311
| -15% | -$2.94M | 0.01% | 1339 |
|
|
2014
Q1 | $27.6M | Sell |
637,862
-136,538
| -18% | -$6.62M | 0.01% | 1071 |
|
|
2013
Q4 | $30.9M | Sell |
774,400
-7,740
| -1% | -$276K | 0.01% | 997 |
|
|
2013
Q3 | $29.4M | Sell |
782,140
-434,905
| -36% | -$13M | 0.01% | 969 |
|
|
2013
Q2 | $32.7M | Buy |
+1,217,045
| New | +$25.9M | 0.02% | 859 |
|
Other funds holding IONS
VPM
VCM
Wells Fargo's IONS Position: Q1 2026 in Review
Wells Fargo reduced its Ionis Pharmaceuticals (IONS) stake by 32% in Q1 2026, selling an estimated $7.12M and leaving 189,853 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1760.
Wells Fargo first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $82.5M in Q1 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Wells Fargo held 189,853 shares of Ionis Pharmaceuticals worth $14.3M as of Q1 2026.
- Wells Fargo sold 90,192 Ionis Pharmaceuticals shares in Q1 2026, an estimated $7.12M.
- Ionis Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1760 holding.
- Wells Fargo first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Ionis Pharmaceuticals position peaked at $82.5M in Q1 2019.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.